Approval · Notice of Compliance 755 · 2002
SALAGEN: Notice of Compliance 755
Issued June 19, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 755
- Date
- June 19, 2002
- Company
- Pharmacia Canada Inc.Baie D'Urfe, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph update regarding use in patients with hepatic impairment and/or renal insufficiency
- Therapeutic class
- Cholinomimetic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SALAGEN | Not yet assigned | — |
Medicinal ingredients
- PILOCARPINE HCL 5 MG per TAB